Advanced search
Publication Cover
Postgraduate Medicine Volume 133, 2021 - Issue 2
Submit an article Journal homepage
1,367
Views
9
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Physicians’ knowledge of potential covid-19 drug–drug interactions: An online survey in turkey

Nursel Sürmelioğlua Department of Clinical Pharmacy, Faculty of Pharmacy, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0001-7758-7100
ORCID Icon,
Nadir Yalçınb Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2280-8727
ORCID Icon,
Ferit Kuşçuc Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0001-5662-8305
ORCID Icon,
Aslıhan Candevirc Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0001-9340-516X
ORCID Icon,
Ayşe Seza İnalc Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0002-1182-7164
ORCID Icon,
Süheyla Kömürc Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0003-2414-559X
ORCID Icon,
Behice Kurtaranc Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0002-2081-4664
ORCID Icon,
Kutay Demirkanb Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-6427-5826
ORCID Icon &
Yeşim Taşovac Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0002-5728-058X
ORCID Icon show all
Pages 237-241 | Received 20 May 2020, Accepted 06 Aug 2020, Published online: 25 Aug 2020

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733.
  • World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report – 119. [cited 2020 May 18]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200518-covid-19-sitrep-119.pdf?sfvrsn=4bd9de25_4
  • Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7;323:1061.
  • Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020 Apr 13. DOI:10.1001/jama.2020.6019
  • Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med. 2020;8(1):e17.
  • Ko Y, Malone DC, Skrepnek GH, et al. Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf. 2008;31(6):525–536.
  • Nabovati E, Vakili-Arki H, Taherzadeh Z, et al. A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran. Int J Clin Pharm. 2017 Jun;39(3):560–568.
  • Ko Y, Malone DC, D’Agostino JV, et al. Potential determinants of prescribers’ drug-drug interaction knowledge. Res Social Adm Pharm. 2008 Dec;4(4):355–366.
  • Roden DM, Harrington RA, Poppas A, et al. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment. Circulation. 2020 Jun 16;141(24):e906–e907.
  • Sarayani A, Cicali B, Henriksen CH, et al. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine [published online ahead of print, 2020 Apr 19]. Res Social Adm Pharm. 2020;S1551-7411(20)30391–0. DOI:10.1016/j.sapharm.2020.04.016
  • Lİverpool Drug Interactions Group. Interactions with COVID-19 Therapies. [cited 2020 Apr 20]. Available from: https://www.covid19-druginteractions.org/
  • Bartiromo M, Borchi B, Botta A, et al. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19). Transpl Infect Dis. 2020 Apr 12;22(4). DOI:10.1111/tid.13286
  • Pirnejad H, Amiri P, Niazkhani Z, et al. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology. Int J Med Inform. 2019;127:18–26.
  • Scavone C, Brusco S, Bertini M, et al. Current pharmacological treatments for COVID-19: what’s next? [published online ahead of print, 2020 Apr 24]. Br J Pharmacol. 2020. DOI:10.1111/bph.15072
  • Malone DC, Liberman JN, Sun D. Effect of an educational outreach program on prescribing potential drug-drug interactions. J Manag Care Pharm. 2013 Sep;19(7):549–557.
  • Back D, Marzolini C, Hodge C, et al. COVID-19 treatment in patients with comorbidities: awareness of drug-drug interactions. Br J Clin Pharmacol. 2020 May 8. DOI:10.1111/bcp.14358
  • UpToDate® Drug Interactions Database. [cited 2020 Apr 22]. Available from: https://www.uptodate.com/contents/search
  • Al-Quteimat OM MSc, BCOP, Amer AM R.Ph, MSc. SARS-CoV-2 outbreak: how can pharmacists help? [published online ahead of print, 2020 Mar 26]. Res Social Adm Pharm. 2020;S1551-7411(20)30238–2.
  • Song Z, Hu Y, Zheng S, et al. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience [published online ahead of print, 2020 Apr 3]. Res Social Adm Pharm. 2020. DOI:10.1016/j.sapharm.2020.03.027
  • Li H, Zheng S, Liu F, et al. Fighting against COVID-19: innovative strategies for clinical pharmacists [published online ahead of print, 2020 Apr 6]. Res Social Adm Pharm. 2020;S1551-7411(20)30328–4. DOI:10.1016/j.sapharm.2020.04.003
  • Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries [published online ahead of print, 2020 Apr 15]. Res Social Adm Pharm. 2020;S1551-7411(20)30332–6. DOI:10.1016/j.sapharm.2020.04.007
  • Liu S, Luo P, Tang M, et al. Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm. 2020 Apr;42(2):299–304.
  • Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic [published online ahead of print, 2020 Apr 6]. Res Social Adm Pharm. 2020. DOI:10.1016/j.sapharm.2020.04.001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.